COCHLEAR LTD UNSP ADR EACH REP - stock earnings
CHEOY Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 130.4 million USD | 758.6 million USD |
| 2023Q2 | 105.5 million USD | 705.3 million USD |
| 2023Q1 | 53.4 million USD | 352.6 million USD |
| 2022Q4 | 96.5 million USD | 608.0 million USD |
| 2022Q3 | 45.9 million USD | 287.2 million USD |
| 2022Q2 | 82.7 million USD | 569.8 million USD |
| 2022Q1 | 44.8 million USD | 309.8 million USD |
| 2021Q4 | 123.0 million USD | 592.2 million USD |
| 2021Q3 | 61.2 million USD | 296.6 million USD |
| 2021Q2 | 67.7 million USD | 562.7 million USD |
| 2021Q1 | 33.5 million USD | 286.5 million USD |
| 2020Q4 | 181.9 million USD | 572.0 million USD |
| 2020Q3 | 84.5 million USD | 266.4 million USD |
| 2020Q2 | -273.3 million USD | 396.6 million USD |
| 2020Q1 | -122.2 million USD | 174.3 million USD |
| 2019Q4 | 110.4 million USD | 544.4 million USD |
| 2019Q3 | 53.5 million USD | 256.4 million USD |
| 2019Q2 | 103.7 million USD | 514.3 million USD |
| 2019Q1 | 52.4 million USD | 256.0 million USD |
| 2018Q4 | 90.6 million USD | 495.8 million USD |
| 2018Q3 | 46.3 million USD | 253.5 million USD |
| 2018Q2 | 99.2 million USD | 524.7 million USD |
| 2018Q1 | 51.9 million USD | 274.4 million USD |
| 2017Q4 | 86.4 million USD | 506.4 million USD |
| 2017Q3 | 43.5 million USD | 254.8 million USD |
| 2017Q2 | 86.3 million USD | 495.6 million USD |
| 2017Q1 | 42.9 million USD | 246.7 million USD |
| 2016Q4 | 80.4 million USD | 439.5 million USD |
| 2016Q3 | 42.5 million USD | 232.4 million USD |
| 2016Q2 | 70.9 million USD | 427.7 million USD |
| 2016Q1 | 36.3 million USD | 219.2 million USD |
| 2015Q4 | 68.5 million USD | 406.5 million USD |
| 2015Q3 | 32.9 million USD | 195.4 million USD |
| 2015Q2 | 57.2 million USD | 374.2 million USD |
| 2015Q1 | 28.5 million USD | 186.5 million USD |
| 2014Q4 | 58.4 million USD | 358.8 million USD |
| 2014Q3 | 31.1 million USD | 191.0 million USD |
| 2014Q2 | 68.4 million USD | 408.7 million USD |
| 2014Q1 | 33.6 million USD | 200.9 million USD |
| 2013Q4 | 18.8 million USD | 331.1 million USD |
| 2013Q3 | 9.8 million USD | 172.6 million USD |
| 2013Q2 | 51.0 million USD | 335.2 million USD |
| 2013Q1 | 28.6 million USD | 188.1 million USD |
| 2012Q4 | 40.3 million USD | 203.5 million USD |
| 2012Q3 | 40.5 million USD | 204.5 million USD |
CHEOY Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 199.4 million USD | 1.3 billion USD |
| 2022 | 199.5 million USD | 1.1 billion USD |
| 2021 | 244.8 million USD | 1.1 billion USD |
| 2020 | -164.5 million USD | 911.4 million USD |
| 2019 | 193.8 million USD | 999.4 million USD |
| 2018 | 180.6 million USD | 1.0 billion USD |
| 2017 | 171.9 million USD | 963.9 million USD |
| 2016 | 141.2 million USD | 844.7 million USD |
| 2015 | 112.0 million USD | 710.8 million USD |
| 2014 | 88.3 million USD | 758.1 million USD |
| 2013 | 123.1 million USD | 698.8 million USD |
| 2012 | 57.0 million USD | 781.8 million USD |
| 2011 | 192.6 million USD | 865.7 million USD |
| 2010 | 130.6 million USD | 618.4 million USD |
| 2009 | 105.3 million USD | 560.2 million USD |
| 2008 | 110.4 million USD | 576.6 million USD |
| 2007 | 84.9 million USD | 474.4 million USD |
| 2006 | 59.4 million USD | 335.9 million USD |
| 2005 | 890715 USD | 263.0 million USD |
| 2004 | 437660 USD | 197.4 million USD |
| 2003 | 38.9 million USD | 192.7 million USD |
| 2002 | 22.6 million USD | 143.7 million USD |
| 2001 | 15.8 million USD | 111.5 million USD |
| 2000 | 12.1 million USD | ? USD |
| 1999 | 10.6 million USD | ? USD |
| 1998 | 8.6 million USD | ? USD |
| 1997 | 7.0 million USD | 47.4 million USD |
| 1996 | 7.1 million USD | 47.0 million USD |
CHEOY
Price: $105.17
Dividend Yield: 0.04%
Forward Dividend Yield: 1.25%
Payout Ratio: 88.62%
Dividend Per Share: 1.31 USD
Earnings Per Share: 1.74 USD
P/E Ratio: 67.16
Exchange: PNK
Sector: Healthcare
Industry: Medical Devices
Volume: 1400
Ebitda: 260.8 millionMarket Capitalization: 13.7 billion
Average Dividend Frequency: 2
Years Paying Dividends: 15
DGR3: 26.12%
DGR5: 15.69%
DGR10: 6.92%